What Adapting During COVID-19 Taught Us About Innovating Drug Development
PharmaTalkRadio27 Huhti 2022

What Adapting During COVID-19 Taught Us About Innovating Drug Development

COVID-19 changed the clinical research landscape by proving the use and efficacy of DCTs, patient-centricity and adaptive designs. Dr Ubavka DeNoble, Executive Vice President of Biotech Operations and Senior Medical Officer of Parexel Biotech shares advice on how CMOs can think about leadership, change management and investing in new technologies such as artificial intelligence, improved data collection and system interoperability to improve patient recruitment and retention and drug development efficacy. Key Takeaways: How to lead with an eye on industry changes and flexibilityThe importance of rewarding innovation rather than standardizing a single approachObservations of successful change management throughout the COVID-19 pandemic

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
rss-mita-tulisi-tietaa
rss-duodecim-lehti
rss-tiedetta-vai-tarinaa
rss-astetta-parempi-elama-podcast
rss-ammamafia
rss-hereilla
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-tervetta-skeptisyytta
rss-kasvikutsut
rss-bios-podcast
ihanat-ipanat
rss-ylistys-elaimille
sotataidon-ytimessa